SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
DARK Classics in Chemical Neuroscience: Psilocybin
16 references·5 citing·27 second hop
DARK Classics in Chemical Neuroscience: Psilocybin (2018)DARK Classics in Chemical Neuroscience: P…The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future (2017)The Therapeutic Potential of …Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017)Psilocybin with psychological…Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences (2016)Survey study of challenging e…Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)Rapid and sustained symptom r…Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study (2016)Psilocybin with psychological…Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Psilocybin produces substanti…Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction (2015)Psilocybin-Occasioned Mystica…Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study (2015)Psilocybin-assisted treatment…Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction (2014)Pilot study of the 5-HT 2A R …Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (2012)Neural correlates of the psyc…Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects (2011)Psilocybin occasioned mystica…Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies (2010)Acute, subacute and long-term…Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder (2006)Safety, Tolerability, and Eff…Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study (2004)Acute psychological and physi…The pharmacology of psilocybin (2002)The pharmacology of psilocybinPsilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Psilocybin induces schizophre…Therapeutic effect of psilocybin in addiction: A systematic review (2023)Therapeutic effect of psilocy…Serotonin 2A Receptor (5-HT 2A R) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants (2023)Serotonin 2A Receptor (5-HT 2…Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice (2022)Structure–Activity Relationsh…Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response (2022)Serotonin 5-HT2A, 5-HT2c and …Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression (2021)Molecular Mechanisms of Psilo…Hallucinogens (2004)Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness (2011)Psychedelics and the essential importance of context (2018)The Yale-Brown Obsessive Compulsive Scale (1989)World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision (2008)The neurobiology of psychedelic drugs: implications for the treatment of mood disorders (2010)The varieties of religious experience: A study in human nature. (1902)Universals in the Content and Structure of Values: Theoretical Advances and Empirical Tests in 20 Countries (1992)Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. (2002)Neural correlates of the LSD experience revealed by multimodal neuroimaging (2016)Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain, and Illness (2008)The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs (2014)Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder (2022)Manual for the State-Trait Anxiety Inventory (1970)The Hospital Anxiety and Depression Scale (1983)Optimism, coping, and health: Assessment and implications of generalized outcome expectancies. (1985)Psychedelics (2016)Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior (2007)Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (2008)REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)Psychedelics Promote Structural and Functional Neural Plasticity (2018)Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (2020)Trial of Psilocybin versus Escitalopram for Depression (2021)Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression (2018)Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders (2020)
this work references cited by second hop

References

  • 2016Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial2,196 cited
  • 2016Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial1,696 cited
  • 2016Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study1,533 cited
  • 2012Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin1,170 cited
  • 2015Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study1,150 cited
  • 1998Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action1,015 cited
  • 2017Psilocybin with psychological support for treatment-resistant depression: six-month follow-up969 cited
  • 2011Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects932 cited
  • 2014Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction913 cited
  • 2006Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder789 cited
  • 2017The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future700 cited
  • 2016Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences555 cited
  • 2010

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies
531 cited
  • 2015Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction475 cited
  • 2002The pharmacology of psilocybin463 cited
  • 2004Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study451 cited
  • Cited by

    • 2021Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression127 cited
    • 2023Therapeutic effect of psilocybin in addiction: A systematic review126 cited
    • 2022Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response108 cited
    • 2022Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice91 cited
    • 2023Serotonin 2A Receptor (5-HT 2A R) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants78 cited